InternationalUSRemember you can easily switch between MIP US and MIP International at any time

India patents

  • What now for compulsory licences?

    March 12, 2012

    Today India has granted its first compulsory licence over a drug. But what of other countries that have used the IP system to make it easier for patients to access medicines?

  • Analysis: India issues first compulsory drugs licence

    March 12, 2012

    In one of his final tasks before leaving the job, the outgoing head of India’s patent office has issued the country’s first compulsory licence over a drug since India began protecting pharmaceutical products seven years ago

  • Bayer loses patent in Indian compulsory licence

    March 12, 2012

    India’s Controller of Patents has issued a compulsory licence over a cancer-treating drug, sorafenib, whose patent is held by Bayer

  • EU-India negotiations prompt patent protests

    February 13, 2012

    The latest round of negotations between the EU and India over a free-trade agreement was disrupted by protests over the way the IP clauses in the deal could affect access to medicines in developing countries

  • First compulsory licence application in India

    September 22, 2011

    Indian generic drug maker Natco has filed a compulsory licence application for the patent covering German pharma company Bayer’s anti-cancer drug Nexavar

  • Head of India’s IP office resigns

    June 20, 2011

    P H Kurian, the reforming head of India’s IP office, has resigned after completing less than half of his five-year term

  • Practitioners back utility model patents for India

    June 14, 2011

    A government consultation paper on introducing a system of utility model patents in India has been welcomed by patent practitioners, who believe it will help to stimulate domestic innovation

  • Beware of India’s Section 8

    May 03, 2011

    The dispute between German wind turbine maker Enercon and its Indian subsidiary has shown that a little known part of India’s Patent Act could have a devastating effect on foreign patent owners

  • German company battles to restore patents in India

    May 03, 2011

    A German company has had 12 patents revoked by its own Indian subsidiary and lost control of its trade mark in a dispute that has raised more questions about India’s IP system

  • India’s Patent Manual leaves questions unanswered

    April 07, 2011

    The final version of India’s long-awaited Patent Manual has failed to clarify some of the grey areas in the country’s patent system

  • Academics challenge India’s IP Appeal Board

    February 11, 2011

    A Court in Chennai has agreed to hear a petition challenging the constitutionality of the tribunal that hears India’s patent and trade mark appeals

  • Third party oppositions: How to oppose patents in Asia

    November 01, 2010

    Gladys Mirandah and David Reed of Patrick Mirandah Co (pmc) discuss third party opposition and invalidation

  • Indian manual raises patent questions

    November 15, 2010

    Practitioners in India have praised the latest draft patent manual for examiners but called for more clarity over software and pharmaceutical patents

  • Creating clarity for IP owners in India

    September 01, 2010

    Greg Kalbaugh tells Peter Ollier about the work the US-India Business Council does to promote IP rights in India

  • Patent manual causes debate in India

    August 22, 2008

    A draft of India’s new manual for patent examiners is causing controversy because of clauses dealing with the patentability of new drugs and software programs

  • India’s IP balancing act

    September 01, 2010

    Thanks to recent patent reforms and its pending membership of the Madrid Protocol, India is firmly part of the global IP system. But, as DIPP joint secretary V Bhaskar tells James Nurton, the country remains sceptical of further harmonisation as it seeks to balance IP protection and development

  • Novartis takes Glivec case to India’s Supreme Court

    August 31, 2009

    Swiss drug maker Novartis has asked India’s Supreme Court to review the patentability of its anti-cancer blockbuster, Glivec

Latest Country Updates


Most read articles